Pharmarise Holdings Corporation (TYO:2796)
Japan · Delayed Price · Currency is JPY 501.00
0.00 (0.00%)
Jun 19, 2026, 3:30 PM JST
Pharmarise Holdings Cash Flow Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Net Income | 8 | 143 | 1,049 | 1,322 | 1,202 |
Depreciation & Amortization | 1,493 | 1,170 | 1,224 | 1,308 | 1,344 |
Loss (Gain) From Sale of Assets | 256 | 297 | 396 | 216 | 50 |
Loss (Gain) From Sale of Investments | -3 | -19 | - | - | 4 |
Other Operating Activities | -426 | -990 | -745 | -869 | -610 |
Change in Accounts Receivable | 392 | 1,437 | 482 | -1,319 | 365 |
Change in Inventory | -1,091 | -26 | 68 | 286 | 56 |
Change in Accounts Payable | 910 | 137 | 13 | -500 | -582 |
Change in Other Net Operating Assets | -228 | 565 | 33 | 269 | 116 |
Operating Cash Flow | 1,311 | 2,714 | 2,520 | 713 | 1,945 |
Operating Cash Flow Growth | -51.70% | 7.70% | 253.44% | -63.34% | 23.73% |
Capital Expenditures | -637 | -472 | -380 | -379 | -508 |
Sale of Property, Plant & Equipment | 3 | 16 | 32 | 2 | 41 |
Cash Acquisitions | -301 | -2,401 | -180 | - | - |
Sale (Purchase) of Intangibles | -65 | -147 | -162 | -87 | -44 |
Investment in Securities | 49 | 43 | - | - | 10 |
Other Investing Activities | -3,510 | -47 | -13 | 171 | -569 |
Investing Cash Flow | -4,462 | -3,120 | -703 | -292 | -1,076 |
Long-Term Debt Issued | 5,100 | 6,100 | 1,700 | 2,000 | 2,500 |
Short-Term Debt Repaid | - | - | - | - | -20 |
Long-Term Debt Repaid | -3,716 | -2,586 | -2,419 | -2,636 | -2,857 |
Total Debt Repaid | -3,716 | -2,586 | -2,419 | -2,636 | -2,877 |
Net Debt Issued (Repaid) | 1,384 | 3,514 | -719 | -636 | -377 |
Repurchase of Common Stock | - | -340 | - | -2 | -36 |
Common Dividends Paid | -224 | -127 | -131 | -131 | -129 |
Other Financing Activities | -221 | -276 | -222 | -265 | -186 |
Financing Cash Flow | 939 | 2,771 | -1,072 | -1,034 | -728 |
Miscellaneous Cash Flow Adjustments | 3 | 1 | -2 | - | -1 |
Net Cash Flow | -2,209 | 2,366 | 743 | -613 | 140 |
Free Cash Flow | 674 | 2,242 | 2,140 | 334 | 1,437 |
Free Cash Flow Growth | -69.94% | 4.77% | 540.72% | -76.76% | 17.50% |
Free Cash Flow Margin | 1.06% | 4.12% | 4.11% | 0.65% | 2.75% |
Free Cash Flow Per Share | 59.53 | 213.04 | 171.61 | 26.94 | 116.15 |
Cash Interest Paid | 191 | 71 | 55 | 66 | 75 |
Cash Income Tax Paid | 436 | 726 | 836 | 870 | 609 |
Levered Free Cash Flow | 457.13 | 2,824 | 1,975 | 221 | 1,420 |
Unlevered Free Cash Flow | 568.38 | 2,866 | 2,009 | 261.63 | 1,466 |
Change in Working Capital | -17 | 2,113 | 596 | -1,264 | -45 |